Followers | 116 |
Posts | 13858 |
Boards Moderated | 0 |
Alias Born | 03/16/2014 |
Monday, July 11, 2016 4:14:52 PM
Burbank, CA – July 11, 2016 – Imaging3™, Inc. (OTCBB: IGNG) announces today that it has successfully completed submission with FINRA and is now approved for trading under the ticker symbol IGNG.
Mr. Dane Medley, Chairman/CEO of Imaging3. “Now that we have reemerged as a public company, we are evaluating new business endeavors, strategic acquisitions and other business transactions to enhance our value to customers and shareholders. We also hope to resubmit our 510(k) application to the Food and Drug Administration. This process will more than likely be managed by an outside consulting firms with specific expertise in navigating the FDA approval process.” Imaging3 will provide ongoing updates in the form of filings and press releases, all of which can be found on our website, www.imaging3.com .
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM